News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
489,856 Results
Type
Article (8327)
Company Profile (140)
Press Release (481191)
Multimedia
Podcasts (4)
Webinars (6)
Section
Business (168022)
Career Advice (309)
Deals (25929)
Drug Delivery (7)
Drug Development (53147)
Employer Resources (14)
FDA (10120)
Job Trends (8704)
News (240235)
Policy (18099)
Tag
2027 Biotech Bay Elite (2)
2027 Biotech Bay Standard (4)
2027 Genetown Elite (1)
2027 Genetown Standard (1)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (1)
Academia (525)
Accelerated approval (24)
ADA (18)
Adcomms (1)
Allergies (96)
Alliances (33381)
ALS (106)
Alzheimer's disease (976)
Antibody-drug conjugate (ADC) (263)
Approvals (10739)
Artificial intelligence (320)
ASCO (159)
Autoimmune disease (205)
Automation (28)
Bankruptcy (264)
Best Places to Work (7072)
BIO (36)
BIOSECURE Act (1)
Biosimilars (110)
BioSpace Insights (17)
Biotechnology (88)
Bladder cancer (139)
Brain cancer (29)
Breast cancer (510)
Cancer (3642)
Cardiovascular disease (218)
Career advice (249)
Career pathing (1)
CAR-T (172)
Celiac Disease (1)
Cell therapy (476)
Cervical cancer (34)
Clinical research (48108)
Collaboration (1243)
Commercialization (3)
Compensation (1453)
Complete response letters (34)
COVID-19 (760)
CRISPR (63)
C-suite (744)
Cystic fibrosis (85)
Data (5666)
Denatured (4)
Depression (102)
Dermatology (61)
Diabetes (341)
Diagnostics (4202)
Digital health (37)
Diversity (1)
Diversity, equity & inclusion (4)
Drug discovery (154)
Drug pricing (8)
Drug shortages (2)
Duchenne muscular dystrophy (166)
Earnings (74176)
Editorial (1)
Employer branding (2)
Employer resources (14)
Events (88182)
Executive appointments (707)
FDA (12773)
Fibrodysplasia Ossificans Progressiva (8)
Friedreich's ataxia (18)
Frontotemporal dementia (23)
Funding (918)
Gene editing (125)
Generative AI (9)
Gene therapy (315)
GLP-1 (296)
Government (964)
Grass and pollen (2)
Guidances (284)
Healthcare (9608)
Hematology (95)
HIV (52)
Huntington's disease (22)
IgA nephropathy (64)
Immunology and inflammation (99)
Immuno-oncology (56)
Indications (161)
Infectious disease (949)
Inflammatory bowel disease (126)
Inflation Reduction Act (4)
Influenza (84)
Intellectual property (255)
Interviews (41)
IPO (12474)
IRA (2)
Job creations (1986)
Job search strategy (239)
JPM (1)
Kidney cancer (16)
Layoffs (61)
Legal (5224)
Licensing (7)
Liver cancer (45)
Longevity (16)
Lung cancer (506)
Lymphoma (249)
Machine learning (27)
Management (3)
Manufacturing (532)
Marketing (8)
MASH (118)
Medical device (9265)
Medtech (9408)
Mergers & acquisitions (14500)
Metabolic disorders (705)
mRNA (53)
Multiple sclerosis (102)
NASH (4)
Neurodegenerative disease (220)
Neuropsychiatric disorders (38)
Neuroscience (1828)
NextGen: Class of 2026 (3213)
Non-profit (886)
Obesity (224)
Opinion (10)
Ovarian cancer (158)
Pain (186)
Pancreatic cancer (195)
Parkinson's disease (201)
Partnered (12)
Patents (474)
Patient recruitment (510)
Peanut (31)
People (41574)
Pharmaceutical (30)
Pharmacy benefit managers (8)
Phase 1 (15516)
Phase 2 (21475)
Phase 3 (14491)
Pipeline (7335)
Policy (19)
Postmarket research (1594)
Preclinical (6566)
Press Release (34)
Prostate cancer (190)
Psychedelics (8)
Radiopharmaceuticals (189)
Rare diseases (572)
Real estate (3071)
Recruiting (6)
Regulatory (14983)
Reports (20)
Research institute (599)
Resumes & cover letters (45)
Rett syndrome (41)
RNA editing (5)
RSV (48)
Schizophrenia (99)
Series A (153)
Series B (123)
Service/supplier (5)
Sickle cell disease (62)
Spinal muscular atrophy (90)
Sponsored (5)
Startups (2044)
Stomach cancer (3)
Supply chain (52)
Vaccines (319)
Venture capital (17)
Weight loss (73)
Women's health (78)
Date
Today (27)
Last 7 days (458)
Last 30 days (1614)
Last 365 days (19203)
2026 (12196)
2025 (19405)
2024 (23187)
2023 (26792)
2022 (34924)
2021 (37555)
2020 (33888)
2019 (23709)
2018 (17874)
2017 (19126)
2016 (18279)
2015 (24633)
2014 (21890)
2013 (18323)
2012 (20433)
2011 (20638)
2010 (20463)
Location
Africa (249)
Alabama (76)
Alaska (2)
Arizona (303)
Arkansas (11)
Asia (18164)
Australia (2151)
California (11963)
Canada (3135)
China (521)
Colorado (491)
Connecticut (412)
Delaware (208)
Europe (25592)
Florida (1807)
Georgia (380)
Hawaii (3)
Idaho (47)
Illinois (703)
India (48)
Indiana (319)
Iowa (14)
Japan (398)
Kansas (101)
Kentucky (31)
Louisiana (27)
Maine (26)
Maryland (1198)
Massachusetts (7848)
Michigan (324)
Minnesota (567)
Mississippi (6)
Missouri (80)
Montana (20)
Nebraska (11)
Nevada (114)
New Hampshire (60)
New Jersey (2624)
New Mexico (12)
New York (2822)
North Carolina (1272)
North Dakota (4)
Northern California (5968)
Ohio (277)
Oklahoma (14)
Oregon (17)
Pennsylvania (2273)
Puerto Rico (20)
Rhode Island (30)
South America (418)
South Carolina (76)
South Dakota (1)
Southern California (4985)
Tennessee (128)
Texas (1936)
United States (38945)
Utah (360)
Vermont (1)
Virginia (159)
Washington D.C. (38)
Washington State (924)
West Virginia (1)
Wisconsin (73)
489,856 Results for "centinel spine inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Centinel Spine® Surpasses 300,000 prodisc® Implantations, Reinforcing Its Leadership in Total Disc Replacement
November 14, 2025
·
4 min read
Press Releases
Centinel Spine® Grows prodisc® Total Disc Replacement 42% Worldwide in Third Quarter 2025 with Record EBITDA Results
October 29, 2025
·
3 min read
Press Releases
Centinel Spine® Receives MDR Certification for prodisc® C Vivo and prodisc® C Nova Cervical Total Disc Replacement Systems
September 12, 2025
·
3 min read
Press Releases
Centinel Spine® Receives Two-Level FDA Approval for prodisc® C Vivo and prodisc® C SK Match-the-Disc™ Cervical Total Disc Replacement Devices
October 15, 2025
·
5 min read
Press Releases
Coverage Expansion Continues for One- and Two-Level Lumbar Total Disc Replacement as One of the Leading Commercial Payers in Arizona Establishes Positive Coverage Criteria for Centinel Spine’s prodisc® L
December 3, 2025
·
3 min read
Press Releases
VB Spine Completes Transaction for CT-Fluoro Technology from Augmedics
August 11, 2026
·
2 min read
Press Releases
Centinel Spine® prodisc® Total Disc Replacement Grows 47% Worldwide in Second Quarter 2025, Setting New Revenue Record
July 23, 2025
·
3 min read
Pharm Country
Centinel Spine® Completes Divestment of its Spine Fusion Business to Silony Spine
Centinel Spine®, LLC announced that it has completed the previously announced agreement to sell its global spine fusion product portfolio and related assets to Silony Spine.
October 19, 2023
·
2 min read
Press Releases
Centinel Spine® Continues to Innovate in Lumbar Total Disc Replacement through the Release of New prodisc® L Instrumentation
June 6, 2025
·
5 min read
Pharm Country
Centinel Spine® to Sponsor Major Worldwide Live Webinar Symposium on Cervical Disc Arthroplasty
Centinel Spine®, LLC (“the Company”) today announced that it will sponsor an upcoming major worldwide live webinar symposium on the current state of TDR options for patients with chronic cervical disc disease.
March 21, 2024
·
3 min read
1 of 48,986
Next
